| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-06 |
| mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-06 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-06 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |